دورية أكاديمية
Relationship between carotid-femoral pulse wave velocity and prognosis in maintenance hemodialysis patients.
العنوان: | Relationship between carotid-femoral pulse wave velocity and prognosis in maintenance hemodialysis patients. |
---|---|
المؤلفون: | Zhu Y; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Li J; Tongxiang Chinese Medicine Hospital, Tongxiang, Zhejiang Province, China., Ding M; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Qiu F; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Zhao Q; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Lu H; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Ren L; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China., Shi Z; Department of Nephrology, The First People's Hospital of Huzhou, Huzhou, Zhejiang Province, China. |
المصدر: | Medicine [Medicine (Baltimore)] 2024 Aug 09; Vol. 103 (32), pp. e39099. |
نوع المنشور: | Journal Article; Observational Study |
اللغة: | English |
بيانات الدورية: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins |
مواضيع طبية MeSH: | Renal Dialysis* , Carotid-Femoral Pulse Wave Velocity*, Humans ; Female ; Male ; Middle Aged ; Prognosis ; Aged ; Kaplan-Meier Estimate ; Kidney Failure, Chronic/therapy ; Kidney Failure, Chronic/physiopathology ; Kidney Failure, Chronic/mortality ; Risk Factors ; Pulse Wave Analysis ; Adult |
مستخلص: | Carotid-femoral pulse wave velocity (Cf-PWV) can well predict the prognosis of the general population. However, whether Cf-PWV can be used as a prognostic indicator in maintenance hemodialysis (MHD) patients remains mysterious. The present study endeavored to explore the prognostic value of Cf-PWV among the MHD population. Patients who received MHD and underwent Cf-PWV examination at the hemodialysis center of Zhejiang Provincial People's Hospital between March 1, 2017 and October 15, 2019 were enrolled. Relevant clinical data were collected from these patients, who were subsequently followed up for a minimum of 1 year. During the follow-up period, the occurrence of all-cause death was recorded as a prognostic indicator. Based on the predetermined inclusion and exclusion criteria 178 patients were included in the final analysis. These patients were categorized into 2 groups based on Cf-PWV values: group 1 (Cf-PWV < 13.8 m/s), and group 2 (Cf-PWV ≥ 13.8 m/s). Thirty-four patients succumbed to their conditions within a median follow-up period of 23.3 months. Kaplan-Meier survival analysis revealed that the median survival time of group 2 was significantly shorter than group 1 (log-rank test, χ2 = 12.413, P < .001). After adjusting for various factors, including age, cardiovascular disease, peripheral arterial diastolic pressure, central arterial diastolic pressure, albumin, blood urea nitrogen, serum creatinine, left ventricular ejection fraction, 25 hydroxyvitamin D3, C-reactive protein and serum phosphorus, it was found that Cf-PWV ≥ 13.8m/s was an independent risk factor for all-cause mortality in MHD patients (relative risk = 3.04, 95% confidence interval [CI] = 1.22-7.57; P = .017). A high level of Cf-PWV (≥13.8 m/s) is an independent risk factor for all-cause death in MHD patients. Competing Interests: The authors have no conflicts of interest to disclose. (Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.) |
References: | Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii28-iii34. (PMID: 30281132) Int J Environ Res Public Health. 2023 Jan 28;20(3):. (PMID: 36767713) J Am Soc Nephrol. 2019 Jun;30(6):918-928. (PMID: 31040188) Clin Cardiol. 2019 Jul;42(7):656-662. (PMID: 31020665) Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7. (PMID: 31704083) Heart Lung Circ. 2021 Nov;30(11):1694-1701. (PMID: 34503918) Arterioscler Thromb Vasc Biol. 2020 May;40(5):1063-1067. (PMID: 32102569) Hemodial Int. 2021 Jan;25(1):71-77. (PMID: 33015982) Hypertension. 2001 Oct;38(4):938-42. (PMID: 11641313) J Clin Med. 2020 Jul 02;9(7):. (PMID: 32630671) Arterioscler Thromb Vasc Biol. 2020 May;40(5):1044-1054. (PMID: 32237903) Int J Cardiol Hypertens. 2020 Nov 11;7:100063. (PMID: 33447784) Am J Kidney Dis. 2019 Feb;73(2):240-247. (PMID: 29908694) Semin Dial. 2018 May;31(3):258-267. (PMID: 29624739) Hypertens Res. 2021 Sep;44(9):1175-1185. (PMID: 34127818) J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. (PMID: 20338492) Clin J Am Soc Nephrol. 2011 Jan;6(1):153-9. (PMID: 20829424) Arterioscler Thromb Vasc Biol. 2020 May;40(5):1034-1043. (PMID: 31875700) J Clin Hypertens (Greenwich). 2020 Sep;22(9):1659-1665. (PMID: 32777179) J Geriatr Cardiol. 2019 Sep;16(9):710-716. (PMID: 31645858) J Hypertens. 2007 Sep;25(9):1751-62. (PMID: 17762635) Front Endocrinol (Lausanne). 2021 Jul 01;12:672350. (PMID: 34276558) |
تواريخ الأحداث: | Date Created: 20240809 Date Completed: 20240809 Latest Revision: 20240811 |
رمز التحديث: | 20240812 |
مُعرف محوري في PubMed: | PMC11315517 |
DOI: | 10.1097/MD.0000000000039099 |
PMID: | 39121296 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1536-5964 |
---|---|
DOI: | 10.1097/MD.0000000000039099 |